ARDS Diagnosis and Management

Diagnostic Criteria

• The American Thoracic Society recommends diagnosing ARDS using the Berlin Definition criteria, which includes acute onset of bilateral pulmonary opacities on chest imaging, arterial hypoxemia with PaO₂/FiO₂ ≤300 mmHg, and respiratory failure not fully explained by cardiac failure or fluid overload 1, 2, 3
• The Berlin Definition criteria for ARDS severity classification is based on PaO₂/FiO₂ ratio, with mild being 200-300 mmHg, moderate being 100-200 mmHg, and severe being <100 mmHg 1, 2, 4

Initial Respiratory Support Strategy

• The American College of Chest Physicians recommends considering high-flow nasal cannula or noninvasive ventilation only in mild ARDS with close monitoring, as failure rates are high in moderate-to-severe cases 2, 3
• The Society of Critical Care Medicine recommends proceeding to early intubation in a controlled setting if deterioration occurs, rather than emergent intubation 2

Lung-Protective Mechanical Ventilation

• The American Thoracic Society recommends immediately implementing lung-protective ventilation in all intubated ARDS patients, with tidal volume of 4-8 mL/kg predicted body weight, plateau pressure ≤30 cmH₂O, and higher PEEP strategy in moderate-to-severe ARDS 1, 2, 4
• The National Institutes of Health recommends targeting SpO₂ no higher than 96% to avoid oxygen toxicity 2

Adjunctive Therapies for Severe ARDS

• The American College of Chest Physicians recommends implementing prone positioning for >12 hours daily in severe ARDS with PaO₂/FiO₂ <100 mmHg, as this intervention has demonstrated significant mortality reduction 1, 2, 4
• The Society of Critical Care Medicine recommends considering neuromuscular blocking agents in early severe ARDS to improve ventilator synchrony, reduce oxygen consumption, and potentially improve outcomes 1, 2, 4

Fluid Management

• The American Thoracic Society recommends implementing a conservative fluid management strategy to minimize pulmonary edema while maintaining adequate organ perfusion 1, 2, 4
• The National Institutes of Health recommends monitoring fluid balance carefully and avoiding fluid overload, as excessive fluid administration worsens oxygenation, promotes right ventricular failure, and increases mortality 1, 2, 4

Advanced Therapies for Refractory Hypoxemia

• The American College of Chest Physicians recommends considering VV-ECMO in selected patients with severe ARDS who fail conventional management, particularly those with reversible disease 1, 2, 3
• The Society of Critical Care Medicine recommends considering a trial of inhaled pulmonary vasodilators as rescue therapy for severe hypoxemia, but discontinuing if no rapid improvement in oxygenation 2

Monitoring Requirements

• The American Thoracic Society recommends continuously monitoring oxygen saturation, respiratory mechanics, hemodynamics, and right ventricular function via echocardiography 1, 2, 4

Weaning and Liberation from Mechanical Ventilation

• The American College of Chest Physicians recommends performing daily spontaneous breathing trials once the patient's condition improves, as this consistently reduces duration of mechanical ventilation 5
• The Society of Critical Care Medicine recommends using noninvasive ventilation after extubation for patients at high risk for extubation failure, to reduce ICU length of stay and mortality 5

ARDS Management Strategies

Initial Respiratory Support

• For patients with mild ARDS, high-flow nasal cannula (HFNC) may be considered, starting at 30-40 L/min with FiO₂ 50-60%, but early intubation in a controlled setting is recommended if deterioration occurs within 1 hour, as suggested by the Military Medical Research journal 6
• HFNC delivers up to 60 L/min gas flow with FiO₂ up to 1.0, and escalation of respiratory support is recommended if FiO₂ >70% and flow >50 L/min for >1 hour, according to the Military Medical Research journal 6
• Contraindications for HFNC include hypercapnia, hemodynamic instability, multi-organ failure, and altered mental status, as noted by the Military Medical Research journal 6

Adjunctive Therapies

• The Military Medical Research journal recommends applying deep sedation and analgesia during prone positioning for severe ARDS patients 6
• Consider cisatracurium infusion for 48 hours in early severe ARDS to improve ventilator synchrony and reduce oxygen consumption, as suggested by the Military Medical Research journal 6
• The Military Medical Research journal notes that neuromuscular blocking agents are particularly beneficial when ventilator-patient dyssynchrony persists despite sedation 6

Advanced Therapies

• VV-ECMO should only be implemented at centers with ECMO expertise, and blood is pumped from the femoral vein and returns to the right atrium through the internal jugular vein after membrane oxygenation, as described by the Military Medical Research journal 6

Monitoring Requirements

• Assess for ventilator-patient dyssynchrony, as recommended by the Military Medical Research journal 6

Non-Invasive Ventilation in Acute Respiratory Distress Syndrome

Patient Selection and Monitoring

• The American Thoracic Society recommends that Non-Invasive Ventilation (NIV) may be considered in patients with mild ARDS (PaO₂/FiO₂ 200-300 mmHg) who have a SAPS II score < 34, are hemodynamically stable, alert, and cooperative, and do not have ARDS caused by pneumonia, with a strength of evidence rated as moderate 7, 8
• Patients with mild ARDS should be closely monitored in an ICU setting, with continuous assessment of respiratory rate and work of breathing, and arterial blood gas analysis at 1-2 hours and again at 4-6 hours if initial improvement is minimal, as recommended by the Society of Critical Care Medicine 7, 8
• The Rapid Shallow Breathing Index (RSBI) should be used to assess the need for intubation, with a value >105 breaths/min/L indicating likely need for intubation, according to the American College of Chest Physicians 7, 8

Contraindications to NIV

• NIV should not be used in patients with impaired consciousness or inability to protect their airway, as recommended by the British Thoracic Society 9, 10
• Patients with hemodynamic instability, copious respiratory secretions, or multi-organ failure should not receive NIV, as stated by the European Respiratory Society 9, 10

Alternative Therapies

• Helmet NIV may be associated with reduced intubation rates and 90-day mortality in ARDS patients, compared to face mask NIV, according to a study published in Critical Care 7, 8
• High-flow nasal cannula (HFNC) may be superior to face-mask NIV in hypoxemic respiratory failure, with significantly lower intubation rates, as recommended by the American Thoracic Society 7, 8

Acute Respiratory Distress Syndrome Management

Ventilator Settings

• The American Thoracic Society recommends implementing lung-protective ventilation with tidal volume 4-8 mL/kg predicted body weight and plateau pressure ≤30 cmH₂O, which is the only intervention proven to reduce mortality in ARDS and represents a strong recommendation suitable as a performance measure 11
• The American Journal of Respiratory and Critical Care Medicine suggests using tidal volume of 4-8 mL/kg predicted body weight (not actual body weight) for lung-protective ventilation 11
• The American Journal of Respiratory and Critical Care Medicine recommends maintaining plateau pressure ≤30 cmH₂O for lung-protective ventilation 11

Adjunctive Therapies

• The American Thoracic Society conditionally recommends using neuromuscular blockers (cisatracurium infusion for 48 hours) in early severe ARDS to improve ventilator synchrony and reduce oxygen consumption, with low certainty of evidence 11
• The American Thoracic Society conditionally recommends administering systemic corticosteroids for ARDS, with moderate certainty of evidence from the 2024 American Thoracic Society guidelines 11

Advanced Rescue Therapies

• The American Journal of Respiratory and Critical Care Medicine conditionally recommends considering VV-ECMO in selected patients with severe ARDS (PaO₂/FiO₂ <100 mmHg) who fail conventional management, particularly those with reversible disease, with low certainty of evidence 11

Critical Pitfalls to Avoid

• The American Journal of Respiratory and Critical Care Medicine strongly advises against using prolonged lung recruitment maneuvers with high PEEP, as it may cause hemodynamic harm and has no mortality benefit 11
• The American Journal of Respiratory and Critical Care Medicine recommends avoiding tidal volumes >8 mL/kg predicted body weight, as it may increase mortality 11